Product information

Current status:

Dormant

Current status date:

2017-08-03

Original market date: ^{See footnote 1}

1996-12-02

Product name:

ORPHENADRINE CITRATE INJECTION, USP

DIN:

02229731 Electronic product monograph is not available

Company:

STERIMAX INC
2770 Portland Drive
Oakville
Ontario
Canada L6H 6R4

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous ,  Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

12:20.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

M03BC01 ORPHENADRINE (CITRATE)

Active ingredient group (AIG) number:^{See footnote5}

0102078002